Semax Laboratory Grade — Netherlands

Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.

Aarise Healthcare exports Semax (CAS: 80714-61-0) to research institutions in Netherlands. Our WHO-GMP certified facility in India supplies 98%+ purity Semax for neuroprotective and cognitive enhancement research.

Semax Export Specifications for Netherlands

Compound	Semax
CAS Number	80714-61-0
Purity	98%+ (HPLC verified)
Form	Lyophilised powder
Regulatory Reference	IGJ/EMA
Shipping	DHL/FedEx temperature-controlled
Transit to Netherlands	5-10 business days
Documentation	CoA, HPLC, MS, export docs

Research Applications of Semax

Semax is used in neuroprotective and cognitive enhancement research. Research institutions in Netherlands source this compound for preclinical studies under applicable IGJ/EMA research regulations.

Why Netherlands Researchers Source Semax from India

• WHO-GMP certified Indian manufacturer — internationally recognised compliance
• Competitive pricing for bulk research quantities
• Full export documentation package for IGJ/EMA compliance
• Temperature-controlled DHL/FedEx shipping to Netherlands
• Dedicated international research supply team
• 98%+ purity guaranteed with independent third-party CoA

Related Peptides in Netherlands

Semaglutide in Netherlands | Tirzepatide in Netherlands | Retatrutide in Netherlands | Liraglutide in Netherlands

Semax — Other Countries

Semax in USA | Semax in UK | Semax in Germany | Semax in Australia

Source from India — Key Manufacturing Cities

Semax in Mumbai, India | Semax in Delhi, India | Semax in Hyderabad, India | Semax in Bangalore, India

Request Semax for your Netherlands research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.